Combining evidence and values in priority setting: testing the balance sheet method in a low-income country by Makundi, Emmanuel et al.
BioMed  Central
Page 1 of 12
(page number not for citation purposes)
BMC Health Services Research
Open Access Research article
Combining evidence and values in priority setting: testing the 
balance sheet method in a low-income country
Emmanuel Makundi1,3, Lydia Kapiriri2 and Ole Frithjof Norheim*3,4
Address: 1National Institute for Medical Research, Dar es Salaam, Tanzania, 2University of Toronto Joint Centre for Bioethics, Toronto, Ontario, 
Canada, 3Centre for International Health, University of Bergen, Norway and 4Division for Medical Ethics, Department of Public Health and 
Primary Health Care, University of Bergen, Norway
Email: Emmanuel Makundi - emakundi@nimr.or.tz; Lydia Kapiriri - Lydia.Kapiriri@utoronto.ca; 
Ole Frithjof Norheim* - ole.norheim@isf.uib.no
* Corresponding author    
Abstract
Background: Procedures for priority setting need to incorporate both scientific evidence and
public values. The aim of this study was to test out a model for priority setting which incorporates
both scientific evidence and public values, and to explore use of evidence by a selection of
stakeholders and to study reasons for the relative ranking of health care interventions in a setting
of extreme resource scarcity.
Methods: Systematic search for and assessment of relevant evidence for priority setting in a low-
income country. Development of a balance sheet according to Eddy's explicit method. Eight group
interviews (n-85), using a modified nominal group technique for eliciting individual and group
rankings of a given set of health interventions.
Results: The study procedure made it possible to compare the groups' ranking before and after
all the evidence was provided to participants. A rank deviation is significant if the rank order of the
same intervention differed by two or more points on the ordinal scale. A comparison between the
initial rank and the final rank (before deliberation) showed a rank deviation of 67%. The difference
between the initial rank and the final rank after discussion and voting gave a rank deviation of 78%.
Conclusion: Evidence-based and deliberative decision-making does change priorities significantly
in an experimental setting. Our use of the balance sheet method was meant as a demonstration
project, but could if properly developed be feasible for health planners, experts and health workers,
although more work is needed before it can be used for laypersons.
Background
Tanzania, as many other countries in sub-Saharan Africa,
needs to improve the way resources are allocated in health
care. Around US$8 are spent per capita on health care per
year, so hard policy decisions have to be made which
affect millions of people [1]. Several building blocks are
now in place to help improve the decision-making proc-
ess. First, the Ministry of Health has adopted the strategy
of identifying a set of core health care services in what they
call an 'essential health care intervention package' [2].
Although this package is defined in broad and somewhat
unspecific terms, it provides a good starting point for allo-
cating resources efficiently and fairly. Second, the country
has embarked upon an ambitious health sector reform,
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involving decentralised planning and financing through
basket funds at regional and district levels. By bringing
decision making closer to the people affected, decentral-
ised planning is thought to facilitate sensitivity to local
priorities and public involvement [3]. Third, the Ministry
has set up a National Sentinel Surveillance System in col-
laboration with the Adult Mortality and Morbidity
project. The aim of this was to provide timely and accurate
information on local and national burden of disease pro-
files so as to improve evidence-based decision making
process [4]. Finally, despite scarcity of evidence on clinical
outcomes and the cost-effectiveness of actual interven-
tions, there is an increasing body of high quality studies
on clinical outcomes and cost-effectiveness relevant for
Tanzania or East-Africa. Through the WHO CHOICE
project, more evidence on the cost-effectiveness of inter-
ventions will become available [5].
At the international level, researchers, political decision-
makers and organisations acknowledge the need to
develop methods for using evidence in resource allocation
which are efficient and seen as fair by the public [6-9]. The
goal of allocative efficiency is based on the notion that
health resources should be allocated across interventions
and population groups to generate the highest possible
overall level of population health [10]. Cost-effectiveness
information is critical in defining a mix of interventions
that would maximise health in the absence of any con-
straints on possible decisions except a finite budget. How-
ever, there are other influences on decisions, such as
political constraints (including dominant interest
groups), donor agencies' priorities, multiple levels of gov-
ernment and dysfunctional financing systems (not further
discussed in this paper). In addition there are distribu-
tional concerns, and concerns about public acceptability
[7]. The last two are requirements of fairness. Fairness
requires that health benefits should be distributed accord-
ing to some notion of equity, and that the public perceives
this distribution as fair [11].
From a health policy perspective, much is known about
the requirements of allocative efficiency. However, there
is less agreement on how to develop political procedures
which secure the requirements of fairness [12]. The issue
of legitimacy has been addressed from two broad perspec-
tives. The first derives its ideas from participatory democ-
racy which requires the involvement of the public in
priority setting [13-17]. The second derives its ideas from
deliberative democracy and ideas of public accountabil-
ity. This argues that procedures can be considered fair if
they satisfy certain conditions, such as publicity, transpar-
ency, the provision of relevant reasons for not providing
services, the existence of proper appeal mechanisms, and
the regulation of the process [11,18,19]. However,
research and development of procedures for resource allo-
cation have not identified agreed methods for identifying,
assessing and validating the evidence that decisions are
based on. There is, therefore, a need for a combined
approach, which acknowledges the crucial importance of
assessing evidence on clinical outcomes and evidence on
cost-effectiveness, and which, at the same time, incorpo-
rates the requirements of legitimacy and fairness. In par-
ticular, key research issues to consider when testing a
priority setting method that combines scientific evidence
and societal values may include: identification of the pri-
orities of a selected sample of stakeholders, whether pro-
vision of evidence affects the respondents' priorities,
whether deliberation and voting processes change partici-
pants' priorities, if respondents' rankings are in any way
different from ranking according to cost-effectiveness, and
finally whether the method is feasible for incorporating
both scientific evidence and societal values into priority
setting processes in various contexts including resource-
poor settings.
This study was motivated by these concerns. We aimed at
testing out the balance sheet method as a model for incor-
porating scientific evidence and societal values in priority
ranking of nine health care interventions in a setting of
extreme resource scarcity.
Methods
In collaboration with local experts in epidemiology and
health planning, we identified six conditions and nine
interventions relevant for an essential health care inter-
vention package in Tanzania. These interventions
included Integrated Management of Childhood Illness
(IMCI), Safe Water (software, i.e. educational tools, not
plumbing etc.), Highly Active Anti-Retroviral Therapy
(AIDS), Voluntary Counselling and Testing (HIV), single
dose Nevirapine (prevention of HIV from mother to
child), Community Based DOTS (for patients with tuber-
culosis and HIV), Community Based DOTS (tuberculosis
only), Intermittent Treatment of Pregnant Mothers
(malaria), and Impregnated Bed Nets (malaria). Before
conducting group interviews with key stakeholders, we
collected several types of evidence in four steps (see fig-
ures 1, 2, 3, 4).
The types of evidence included were all based on criteria
that have been proposed as relevant in the literature on
priority setting, such as prevalence, disease burden, cover-
age, severity of disease (annual risk of death or disease
without intervention), efficacy (relative risk-reduction of
mortality), cost-effectiveness, and equity [16]. These crite-
ria are not derived from a unified framework of criteria for
priority setting, but were selected because we wanted to
test whether they were also considered relevant for our
respondents.BMC Health Services Research 2007, 7:152 http://www.biomedcentral.com/1472-6963/7/152
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Step I: Assessment of evidence on prevalence, disease 
burden and coverage of the selected conditions
The Global Burden of Disease Study and the East African
Regional Study provided data on incidence and preva-
lence [20]. A systematic search on Medline was added to
develop best estimates on incidence and prevalence [21-
29]. We also contacted national experts for the selected
conditions, for validation of our data and asked them to
give their own estimates based on their experience in the
various fields. They also gave us local estimates for the
coverage of the selected interventions. The local organisa-
tions contacted included relevant departments at the Min-
Evidence presented to the participants Figure 1
Evidence presented to the participants. Balance sheet 1. Estimates of need: Prevalence, burden of disease and coverage.
Condition  Pneumonia  Diarrhoe
a
HIV/AIDS      HIV/AIDS  HIV
transmission 
from mother 
to child 
Tuberculosis 
+ HIV 
Tuberculosis Malaria  Malaria 
Intervention  Integrated 
Management 
of Childhood 
Illness (IMCI) 
Safe water 
(software) 
Highly 
active anti-
retroviral 
therapy 
(HAART) 
Voluntary 
Counselling 
and Testing 
(VCT) 
Single dose 
Nevirapine 
(targeted 
treatment) 
Community 
based DOTs 
Community 
based DOTs 
Intermittent 
treatment 
of pregnant 
mothers 
Impregnated 
bed nets 
Prevalence  (%)  14   12   32.1 *
4.0  **  
32.1 *
4.0 **  
13.7 44 ***  0.4   9.4    30.9 -  
55.4
Burden of 
disease#
Dar es Salaam  
5.1  0.9  13.5  13.5  1.4  17.6  3.9  2.9  7.9 
Coverage (%) – 
expert estimates 
37   40-50  < 1 < 5 2 100   100   30   12  
Data Sources  National 
Bureau of 
Statistics,
1999 
National 
Bureau of 
Statistics,
1999 
National 
AIDS 
Control 
Programme, 
2000 
National 
AIDS 
Control 
Programme, 
2000 
Kilewo 2001 
Kwesigabo 
2000 
Range 2001  Global TB 
Programme, 
WHO, 2002 
Mnyika, 
2000 
Malaria 
Control 
Pro-
gramme, 
2002 
Drakeley 
2000 
Wakibara, 
1997 
Malaria 
Control 
Programme, 
2002 
*   = Urban, Iringa; ** = Rural, Mwanza; *** = Percentage of TB-patients with HIV; # = MoH/AMMP data 
Evidence presented to the participants Figure 2
Evidence presented to the participants. Balance sheet 2. Clinical outcomes.
Condition  Pneumonia  Diarrhoea  HIV/AIDS  HIV/AIDS  HIV
transmission 
from mother 
to child 
Tuberculosis 
+ HIV 
Tuberculosis Malaria  Malaria 
Intervention  Integrated 
Management 
of Childhood 
Illness 
(IMCI) 
Safe water 
(software) 
Highly 
active anti-
retroviral 
therapy 
(HAART) 
Voluntary 
Counselling 
and Testing 
(VCT) 
Single dose 
Nevirapine 
(targeted 
treatment) 
Community 
based DOTS 
Community 
based DOTS 
Intermittent 
treatment 
of pregnant 
mothers 
Impregnated 
bed nets 
Annual risk (%) 
of death/disease 
without 
intervention  
7.7   1.3   > 30 1.9   
(risk of HIV) 
25-35  
(risk of HIV 
transmission) 
>> 42  42 NA 1.9  
Efficacy (%)  
Relative risk 
reduction of 
mortality
80 %  20 %  73 %   895/10 000 
(cases
averted) 
47   78 (cure rate)  78  (cure rate)  205/10 000 
(deaths 
averted) 
19  
NA = Not available BMC Health Services Research 2007, 7:152 http://www.biomedcentral.com/1472-6963/7/152
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istry of Health (the National Malaria Control Programme,
the National TB Control Programme, the Integrated Man-
agement of Child Illness Programme, the National AIDS
Control Programme), and the Adult Mortality and Mor-
bidity Project (AMMP), as well as key organisations such
as the Tanzanian Essential Health Care Intervention
Project (TEHIP), and the regional WHO office. From
AMMP we received updated burden of disease estimates
Evidence presented to the participants Figure 3
Evidence presented to the participants. Balance sheet 3. Cost-effectiveness. The search for evidence was restricted to the 
period 1995–2002. Especially for HART, new evidence on cost-effectiveness has been published, and this evidence might 
potentially have changed the ranking of interventions.
Condition  Pneumonia  Diarrhoe
a
HIV/AIDS  HIV/AIDS  HIV
transmission 
from mother 
to child 
Tuberculosis 
+ HIV 
Tuberculosis Malaria  Malaria 
Intervention  Integrated 
management 
of childhood 
illness 
(IMCI) 
Safe water 
(software) 
Highly 
active anti-
retroviral 
therapy 
(HAART) 
Voluntary 
Counselling 
and Testing 
(VCT) 
Single dose 
Nevirapine 
(targeted 
treatment) 
Community 
based DOTs 
Community 
based DOTs 
Intermittent 
treatment of 
pregnant 
mothers 
Impregnated  
bed nets 
Total costs per life 
year saved (USD) 
3 1800 
Total cost per DALY 
saved (USD) 
---  27 ---  18 11 14-21  14-21  4-29  19-85 
Quality of evidence: 
(Poor/average/good) 
Poor Average  Average  Average  Good  Average  Average  Average  Good 
Data sources  Jha 1998  Varley, 
1998 
Creese,
2002 
Harries, 
2001 
Creese,
2002 
Sweat, 2000 
Creese, 2002 
Marseille,
1999 
Creese, 2002, 
Floyd, 1997 
Creese, 2002, 
Floyd, 1997 
Jha 1998 
Goodman, 
1999; 2000 
Goodman,  
1999; 2000 
* The search for evidence was restricted to the period 1995-2002. Especially for HART, new evidence on cost-effectiveness has been published, 
and this evidence might potentially have changed the ranking of interventions.
Evidence presented to the participants Figure 4
Evidence presented to the participants. Balance sheet 4. Equity considerations.
Condition  Pneumonia  Diarrhoe
a
HIV/AIDS  HIV/AIDS  HIV
transmissi
on from 
mother to 
child
Tuberculosi
s + HIV 
Tuberculosis Malaria  Malaria 
Intervention  Integrated 
Management 
of Childhood 
Illness 
(IMCI) 
Safe water 
(software) 
Highly 
active anti-
retroviral 
therapy 
(HAART) 
Voluntary 
Counselling 
and Testing 
(VCT) 
Single 
dose 
Nevirapine 
(targeted 
treatment) 
Community 
based DOTs 
Community 
based DOTs 
Intermittent 
treatment of 
pregnant 
mothers 
Impregnated  
bed nets 
Age (years)  < 5  < 5  19 - 45  19 – 45  < 2  19 – 45  15 – 44  15 – 49  < 5 
Area of 
residence
Poor
(ventilation) 
Poor Urban  Urban  Urban  Urban  Urban  Equal Equal
Household 
income
Poor Poor Equal Equal                 Equal Poor Poor Equal Equal
Gender Equal Equal Women > 
men 
Women > 
men 
Equal Men > 
women 
Men > 
women 
Women  Equal
Political voice 
or pressure 
groups
Low Average  High  High  High  Average  Average  Average  Average BMC Health Services Research 2007, 7:152 http://www.biomedcentral.com/1472-6963/7/152
Page 5 of 12
(page number not for citation purposes)
for Dar es Salaam region and Hai district, the closest
approximation of disease burden in the nearby Moshi dis-
trict [see Additional file 1] [30,31].
Step II and III: Review of evidence on cost-effectiveness of 
selected interventions
We conducted a systematic search in Medline and the
Cochrane database for studies on cost-effectiveness for all
the identified health interventions. We used the search
terms: 1) "condition/intervention", 2) "cost*effective-
ness", and 3) "Tanzania" or "sub-Saharan Africa", for the
period of 1995–2002. The search term for country was
broadened if no records were found. Preference was given
to studies where details of costs and benefits were clearly
presented and where the outcome measures were either
life years or disability adjusted life years saved – studies
used: [32-43]. We did not conduct a separate search on
clinical outcomes, but identified randomised clinical tri-
als and meta-analyses used in the actual cost-effectiveness
studies.
Step IV: Critical review of literature on equity and political 
concerns in the distribution of health benefits
Finally, we undertook a critical review of the literature on
health policy and equity issues in the distribution of
health benefits, from which we developed a list of group
characteristics of the target population relevant to equita-
ble health policy [16,44,45]. The list included age, area of
residence, household income, gender, and political voice.
We described each target group according to this list, and
the validity of these descriptions was itself a topic for dis-
cussion in the group interviews (see study procedure, step
6).
The information obtained was presented in an explicit
and neutral manner to the respondents, in the form of a
Balance Sheet, developed according to David Eddy's
method [46]. The criteria used in the balance sheet
method overlaps considerably with those used by Eddy,
but the researchers made the final decision about the rel-
evant criteria.
Sampling
Through the National Institute for Medical Research, we
identified eight groups of stakeholders in priority setting
in health, of which four were from an urban setting (Dar
es Salaam), and four from a rural setting (Moshi). These
included representatives from the general population,
health workers, national and district planners (of the
Health Sector) and one patient group (people living with
HIV/AIDS). We obtained informed consent from all par-
ticipants. Each group comprised of eight to thirteen adult
participants:
1. Moshi District
i) Moshi District Health Management Team (DHMT)
members (8 participants)
ii) Mawenzi hospital health workers (doctors and nurses)
(13 participants)
iii) People living with HIV/AIDS (10 participants)
iv) Lay people from Makuyuni village (10 participants)
2. Dar es Salaam
i) Temeke Municipal Health Management Team members
(13 participants)
ii) Lay people from Chamazi village (11 participants)
iii) Muhimbili National Hospital health workers (doctors
and nurses) (10 participants)
iv) Ministry of Health officials (10 participants).
The modified nominal group interview
We conducted an interview study using the nominal
group technique [47]. The original nominal group inter-
view can be described as a focus group interview with vot-
ing on key issues [48]. We employed a modified nominal
group technique. Our modification consisted of introduc-
ing evidence in a stepwise manner and allowing more dis-
cussion of conflicting issues before voting. The use of
votes is thought to overcome the usual unequal represen-
tation of opinions. This method is considered to be better
than focus groups for generating ideas and getting equal
participation from group members.
Study procedure
Each group interview lasted about 3–4 hours. Each group
session began with self-introductions, introduction of the
purpose of the interview, as well as discussion of the
selected conditions and their interventions to ensure a
common understanding. After this, with the facilitation of
the investigators, each group went through eight sessions:
1. Participants were asked to rank the interventions with-
out any evidence and prior to any discussions. The ques-
tion asked: "Please rank the interventions according to
your personal view of perceived importance. As more
resources become available, they will be used according to
the rank order given."
2. After this, participants were requested to imagine they
were health planners interested in the population health
of their society. The question asked: "Imagine now that
you are health planners: How would you rank the inter-
ventions?" The group discussed the interventions pre-BMC Health Services Research 2007, 7:152 http://www.biomedcentral.com/1472-6963/7/152
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sented and came up with a priority ranking of the
interventions by the whole group, through consensus, or
if necessary through voting.
3. Presentation of estimates of prevalence, burden of dis-
ease, and coverage (balance sheet 1) followed by individ-
ual ranking.
4. Presentation of information on clinical effectiveness
(balance sheet 2) followed by individual ranking.
5. Presentation of information on cost- effectiveness of
the interventions (balance sheet 3) followed by individual
ranking.
6. Presentation of group characteristics for each condition
(balance sheet 4). The respondents were asked to discuss
the validity of this information and its relevance for equity
considerations. They were then asked to do the final indi-
vidual ranking based on all the evidence given.
7. Participants were asked to imagine they were health
planners again. They discussed the interventions and
came up with a priority ranking of the interventions by the
whole group, through consensus or voting.
8. Brief evaluation of the methodology and summing up.
All group discussions were actively facilitated and partici-
pants had opportunities to ask for clarifications. Presenta-
tion of the evidence (the wording and use of technical
terms such as risk reduction or odds ratios) varied accord-
ing to the informant's level of expertise. Where appropri-
ate, discussions were carried out in Kiswahili. All
participants gave their written informed consent, and eth-
ical and scientific clearance for this study was obtained
from Medical Research Co-ordinating Committee of the
National Institute for Medical Research of Tanzania.
Analysis
We collected each respondent's ranking before any evi-
dence was given, and after introduction of the four kinds
of evidence outlined above. All the individual rankings
were tabulated into a spreadsheet, and we calculated
mean rankings from each group and for all participants.
Eight groups were convened with a total of 85 respond-
ents, but three responses (two from the village group),
had to be excluded because of obvious misunderstandings
and inconsistencies. We present descriptive statistics for
the remaining 82 respondents. The two rankings obtained
through consensus or voting before and after all the evi-
dence were tabulated separately, and the mean for all
groups was calculated (representing average rankings for
all groups after deliberation). While aggregation of the
ranks masks the individual- and group-differences, the
purpose of this paper was to test the application of the
tool. Detailed discussion of the differences between indi-
vidual groups will be presented elsewhere.
For comparison of different rankings, we defined a rank
deviation as significant if the rank order of the same inter-
vention differed by two or more points on the ordinal
scale. Difference in rank order is expressed as a ratio
between the interventions with significant rank deviation
over the total number of interventions.
Results
The main result from the sample of stakeholders in Tanza-
nia, as expressed after all the evidence was received and
discussed, is that Integrated Management of Childhood
Illness (IMCI) should be considered the first priority, fol-
lowed by Voluntary Counselling and Testing (VCT) and
Prevention of Vertical Transmission of HIV from mother
to child with single dose Nevirapine (both ranked as
number two). The three interventions with the lowest pri-
ority were intermittent treatment of pregnant mothers
with malaria (rank seven), followed by Directly Observed
Treatment for tuberculosis (DOTS) for patients with the
combined diagnosis of tuberculosis and HIV. Highly
Active Anti-Retroviral Therapy (HAART) for HIV/AIDS
was ranked lowest (table 1).
Our study procedure made it possible to compare the
groups' ranking before and after all the evidence was given
(figure 5). Based on comparisons of rank, the difference
between the initial rank versus the final rank (before dis-
cussion and voting) was a rank deviation of 67% (6/9).
We also tested whether deliberation and voting changed
the rank order. The difference between the initial rank ver-
sus the final rank after discussion and voting was a rank
deviation of 78% (7/9).
From our data, we were also able to explore how evidence
and deliberation changed the rank order of various inter-
ventions. Three examples are given in figure 6. Software
for safe water, e.g. educational tools, was initially consid-
Table 1: Final ranking after deliberation and voting, mean rank, 
all groups
Final ranking after deliberation and voting
IMCI 1
Voluntary Counselling and Testing (VCT) 2
Nevirapine (prevention of HIV from mother to child) 2
DOTs (TB alone) 4
Bed nets (malaria) 5
Safe water 6
Intermittent treatment with SP (malaria) 7
DOTs (+ HIV) 8
Anti-retroviral therapy (HAART) 9BMC Health Services Research 2007, 7:152 http://www.biomedcentral.com/1472-6963/7/152
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ered second priority. When evidence of need was pre-
sented (life years lost from diarrhoea is reported to be
about 1% of the total burden of disease), the rank
dropped, and dropped further when the mortality reduc-
tion of 20% was presented. Ranking improved somewhat
when the cost-effectiveness of $27 per life year saved was
considered, and the intervention resumed its rank
number two when the respondents considered that diar-
rhoea is a condition typically affecting poor people with a
low political voice. In the overall discussion, the relative
rank dropped to number six. Highly Active Anti-Retroviral
Therapy (HAART) was consistently given lowest priority,
except when the favourable clinical outcomes were exam-
ined. The prevention of vertical transmission of HIV from
mother to child with Nevirapine got a low rank initially,
but improved significantly to rank number two when the
favourable cost-effectiveness ratio (11$ per DALY saved)
was presented.
Although ranking interventions according to data from
different studies in a league table form is methodologi-
cally problematic, we wanted to test how the participants'
rank order compared with such a league table (figure 7).
The league table is based on median point estimates of
cost-effectiveness, even if some of the studies used
expressed interval estimates. We found that the respond-
ents' rankings differed only slightly from ranking accord-
ing to cost-effectiveness. Rank deviation was 33% (3/9).
The most marked deviations were for Intermittent Treat-
ment with sulfadoxine-pyrimethamine (SP) for pregnant
women to prevent malaria, DOTS for patients with tuber-
culosis and HIV, and Insecticide-treated Bed Nets. In dis-
cussions, respondents gave various reasons for their
ranking. For Intermittent Treatment with SP, many
experts expressed concerns about the lack of evidence
from randomised clinical trials on the assumed mortality
reduction from this intervention (a fact acknowledged in
the original cost-effectiveness study). DOTS for patients
with TB and HIV was given low priority since, as some
said, life expectancy for these patients is shorter because of
lack of access to anti-retroviral therapy in the country.
Others supported the current TB policy in Tanzania
(which assigns equal priority to all with TB regardless of
HIV status). The Impregnated Bed-Nets strategy was given
high priority by many because malaria is the major cause
of under-five mortality, and participants felt that an inter-
vention addressing this problem was important.
Relative ranking of interventions Figure 5
Relative ranking of interventions. Comparison of rank order before and after evidence was provided, and after the final delib-
eration and voting.
1
2
3
4
5
6
7
8
9
Bed nets
Safe water
IMCI
Intermittent treatment
VCT
DOTs
Nevirapine
DOTs (HIV)
HAART
Rank 1 (no evidence)
Rank 5 (all evidence)
Final rankBMC Health Services Research 2007, 7:152 http://www.biomedcentral.com/1472-6963/7/152
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Is the balance sheet method feasible for involving patients
and the public? Our results from the patient group are
somewhat discouraging in this respect (figure 8). Patients
living with HIV/AIDS consistently ranked all interven-
tions related to HIV on top, despite all the evidence given.
It is, however, interesting to observe that voluntary coun-
selling and testing (VCT) got a clear priority over HAART,
even if this preferences would not favour patients' own
condition as much as HAART. This might indicate that
overwhelming evidence on the cost-effectiveness of VCT
contributes to reasonableness in open discussion.
The interviews in the village groups (n = 21) gave valuable
inputs, but in analysing the material we found that many
participants found the ranking process difficult and we
had to exclude two of the individual rankings because
they were inconsistent. In the evaluation, many partici-
pants said that they found the information too technical
to comprehend. Two of the participants could not read,
and many had difficulties with numbers. We found the
balance sheet approach more relevant and useful for
health workers and planners.
Discussion
Our study suggests that evidence-based and deliberative
decision-making does change priorities significantly in an
experimental setting in a low-income country. This con-
firms findings from UK [49]. Informed decision-making
with the use of the balance sheet approach is feasible for
health planners, experts and health workers, but can be
less so for laypersons. The study demonstrates some of the
strengths of the balance sheet method. It brings evidence
and other reasons to the table and provides a common
arena for debate. It helps sort out relevant arguments, and
encourages critical assessment of evidence so that reasons
for rationing can be made explicit.
There is partial overlap with the criteria our respondents
found important and those found in a very interesting dis-
crete choice experiment from Ghana [50]. That study was
Relative ranking of interventions Figure 6
Relative ranking of interventions. How evidence and deliberation change the relative rank of three selected interventions.
1
2
3
4
5
6
7
8
9
No evidence Need
Clinical
outcomes
Cost-
effectiveness Equity Final rank
Safe water HAART NevirapineBMC Health Services Research 2007, 7:152 http://www.biomedcentral.com/1472-6963/7/152
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carried out to determine the relative importance of differ-
ent criteria in identifying priority interventions in Ghana
and found that interventions that are cost-effective, reduce
poverty, target severe diseases, or target the young had a
higher probability of being chosen than others. Our study
was not designed to identify the relative importance of
each criterion and the results can therefore not be directly
compared.
There are several weaknesses to the study. We presented
realistic choices in a hypothetical choice situation. The
exercise is hypothetical in two ways: First, we did not
present all available evidence to the participants. The
amount of potentially relevant information is much larger
than the selection we chose. In this sense, we limited the
reasons participants could take into consideration. Sec-
ond, policy makers must typically compare more than a
few interventions at a time (the WHO-CHOICE database
project aims to produce data for about 500 interventions).
One of the major shortcomings of the balance sheet
method is that its priority ranking results seem to be lim-
ited to the interventions included in the study design.
Results will obviously change when other alternatives are
introduced. However, all methods for priority setting that
rely on evidence and comparisons of alternatives are
incomplete if they do not include all relevant alternatives.
Starting with a limited set of interventions and making the
evidence explicit is only the first step for comprehensive
priority setting. At a later stage more interventions and
types of evidence can be included. What our study shows
is that discussion of evidence and values may change pri-
orities, and this way of making the process more transpar-
ent may be an advantage also in real-world situations
where the alternatives are many and complex.
Moreover, the choice situation we created was highly con-
text sensitive. For example, we reported that coverage for
treatment of smear positive patients with tuberculosis is
almost 100 percent. This might have influenced the prior-
ity assigned to treatment for this condition (i.e. coverage
is already almost complete).
Relative ranking of interventions Figure 7
Relative ranking of interventions. Final rank compared with ranking according to cost-effectiveness ratios.
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We did not ask respondents about re-allocations, and that
this could be seen as a major drawback of the tool. How-
ever, there is nothing in the tool itself that prohibit
rephrasing the question posed to the respondents – so
that re-allocation is also considered.
The search for evidence was restricted to the period 1995–
2002. Especially for HAART, new evidence on cost-effec-
tiveness has been published since, and this evidence
might have changed the ranking of interventions. A less
narrow search strategy could also have changed our
results, i.e. we could have included studies from outside
sub-Saharan Africa, and cost-effectiveness studies with
other outcome measures than life years or DALYs. Moreo-
ver, we presented evidence on clinical outcomes based on
results from meta-analyses and studies used in key cost-
effectiveness studies. Performing a systematic search and
full evaluation of all possibly relevant clinical studies for
all nine interventions is extremely resource and time
demanding, and we therefore assumed that key studies
had already been identified in this way in the meta-analy-
ses and the economic studies we used. However, our sim-
plified approach could have introduced biases that the
reader should be aware of.
With regards to the composition of the respondent
groups, we chose homogenous groups because given the
cultural-, social- and gender- norms in this society; domi-
nance of educated males may have been unavoidable.
Homogeneous groups are typically considered better to
avoid dominance from single individuals with expert sta-
tus.
Although the respondents gave reasons for their ranking
and these would add understanding of the rankings, we
do not report analysis of them here. This paper is the first
exploration of this tool and its application. Details of the
reasons and discussions during the deliberation will be
presented elsewhere.
In the evaluation, the respondents expressed that they did
not have enough time to understand all the information.
The balance sheet is difficult for laypersons and non-med-
ical planners to understand, but even experts in the fields
Relative ranking of interventions Figure 8
Relative ranking of interventions. Ranking from the patient group (people living with HIV/AIDS).
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complained about the complexities of choice: four sets of
evidence for nine interventions had to be balanced at the
same time. On the other hand, it is hard to see how to
reduce the complexities of this kind of decision-making.
Many expressed the need for capacity building with
respect to summarising the evidence base. Finally, some
expressed concern that the discussion and voting proce-
dure was easy to manipulate, eloquent rhetoricians
tended to influence the consensus, or the open voting. We
could have used secret ballots.
Overall, the study suggests that many of the arguably most
important decisions in priority setting – such as the assess-
ment and interpretation of evidence – are so technical that
they are not feasible for direct participation from the pub-
lic. However, the balance sheet promotes what we will call
internal accountability through explicitness, transparency
and a commitment to scientific validity. This fits more
easily into the deliberative framework advocated by
among others Daniels and Sabin, focusing on accounta-
bility for reasonableness [11]. Requirements other than
participation are probably needed for securing external
accountability, that is, accountability to the public.
Conclusion
The results from our exploratory study concerning ranking
should not be generalized as an expression of all stake-
holders' views for policy decisions in Tanzania. We do,
however, think that the balance sheet method indicates
some elements which are needed to improve resource
allocation processes in Tanzania. As a first step, there is a
need for institutional strengthening in terms of capacity
building for the identification, assessment and interpreta-
tion of available evidence. The methods and tools of evi-
dence-based medicine provide a useful starting point for
such capacity building [51]. In addition, there is a relative
scarcity of evidence from randomized clinical trials and
cost-effectiveness studies relevant for this area. Strength-
ening national research involvement and building capac-
ity to make use of the WHO-CHOICE databases is also
important. With these building blocks in place, health
authorities at all levels would have the opportunity to
improve health policy through informed debate.
Although there's increasing recognition of the relevance of
involving the public in priority setting, the limitations of
their ability to decipher medical evidence has made it dif-
ficult to implement. This study provides a method that
could facilitate meaningful public involvement in priority
setting. However, there is need for more research to
explore how this would play out in real life planning situ-
ations.
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